245 related articles for article (PubMed ID: 9857110)
21. The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer.
McKeown DJ; Brown DJ; Kelly A; Wallace AM; McMillan DC
Br J Cancer; 2004 Dec; 91(12):1993-5. PubMed ID: 15570310
[TBL] [Abstract][Full Text] [Related]
22. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED
J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
[TBL] [Abstract][Full Text] [Related]
23. Circulating levels of soluble CD30 and other markers in colorectal cancer patients.
Iwagaki H; Hizuta A; Kohka H; Kobashi K; Nitta Y; Isozaki H; Takakura N; Tanaka N
J Med; 1999; 30(1-2):111-21. PubMed ID: 10515247
[TBL] [Abstract][Full Text] [Related]
24. Drug-induced hyperergic vasculitis--activity of selected cytokines and acute phase proteins in plasma.
Chodorowska G; Czelej D
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):43-7. PubMed ID: 15314957
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory mediators and immune function are altered in home parenteral nutrition patients.
Hise ME; Compher C; Harlan L; Kohlmeier JE; Benedict SH; Gajewski B; Brown JC
Nutrition; 2006 Feb; 22(2):97-103. PubMed ID: 16459221
[TBL] [Abstract][Full Text] [Related]
26. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia.
Kupferminc MJ; Peaceman AM; Aderka D; Wallach D; Socol ML
Obstet Gynecol; 1996 Sep; 88(3):420-7. PubMed ID: 8752252
[TBL] [Abstract][Full Text] [Related]
27. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes.
O'Malley T; Ludlam CA; Riemermsa RA; Fox KA
Eur Heart J; 2001 Jul; 22(14):1226-34. PubMed ID: 11440495
[TBL] [Abstract][Full Text] [Related]
28. The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer.
Ramsey S; Lamb GW; Aitchison M; McMillan DC
Br J Cancer; 2006 Oct; 95(8):1076-80. PubMed ID: 17003778
[TBL] [Abstract][Full Text] [Related]
29. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients.
Vilarrasa N; Vendrell J; Sánchez-Santos R; Broch M; Megia A; Masdevall C; Gomez N; Soler J; Pujol J; Bettónica C; Aranda H; Gómez JM
Clin Endocrinol (Oxf); 2007 Nov; 67(5):679-86. PubMed ID: 17608757
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the effect of serum interleukin-6 (IL-6) and soluble IL-6 receptor levels on survival of patients with colorectal cancer.
Yeh KY; Li YY; Hsieh LL; Lu CH; Chou WC; Liaw CC; Tang RP; Liao SK
Jpn J Clin Oncol; 2010 Jun; 40(6):580-7. PubMed ID: 20194250
[TBL] [Abstract][Full Text] [Related]
31. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
[TBL] [Abstract][Full Text] [Related]
32. Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease.
Tilg H; Vogel W; Wiedermann CJ; Shapiro L; Herold M; Judmaier G; Dinarello CA
Hepatology; 1993 Nov; 18(5):1132-8. PubMed ID: 8225219
[TBL] [Abstract][Full Text] [Related]
33. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
Nagaki M; Iwai H; Naiki T; Ohnishi H; Muto Y; Moriwaki H
J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Prato B; Prontera C; Facchini V; Genazzani AR
Anticancer Res; 1996; 16(5B):3125-8. PubMed ID: 8920779
[TBL] [Abstract][Full Text] [Related]
35. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
Nassonov EL; Samsonov MY; Tilz GP; Beketova TV; Semenkova EN; Baranov A; Wachter H; Fuchs D
J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
[TBL] [Abstract][Full Text] [Related]
36. Soluble interleukin-2 receptor: a new marker in pancreatic adenocarcinoma?
Rabitti PG; Pacelli L; Uomo G; Laccetti M; Spada OA; Esposito G; Visconti M
Minerva Gastroenterol Dietol; 1994 Sep; 40(3):101-3. PubMed ID: 7948318
[TBL] [Abstract][Full Text] [Related]
37. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha.
Comini L; Bachetti T; Agnoletti L; Gaia G; Curello S; Milanesi B; Volterrani M; Parrinello G; Ceconi C; Giordano A; Corti A; Ferrari R
Eur Heart J; 1999 Oct; 20(20):1503-13. PubMed ID: 10493849
[TBL] [Abstract][Full Text] [Related]
38. Serum cytokine levels in patients undergoing bone marrow transplantation.
Chasty RC; Lamb WR; Gallati H; Roberts TE; Brenchley PE; Yin JA
Bone Marrow Transplant; 1993 Oct; 12(4):331-6. PubMed ID: 8275032
[TBL] [Abstract][Full Text] [Related]
39. Serum soluble interleukin-2 receptor in pancreatic cancer and chronic pancreatitis.
Pezzilli R; Billi P; Beltrandi E; Mancini R; Casadei-Maldini M; Casadei R; Greco VM; Campione O; Miglioli M
Ital J Gastroenterol; 1994 Apr; 26(3):137-40. PubMed ID: 8061340
[TBL] [Abstract][Full Text] [Related]
40. C reactive protein in pancreatic cancer and chronic pancreatitis.
Basso D; Fabris C; Meani A; Del Favero G; Vianello D; Angonese C; Meggiato T; Bellinvia S; Fogar P; Petrin P
Ann Clin Res; 1988; 20(6):414-6. PubMed ID: 3218913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]